戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 th no biopsy/normal histology and high-grade squamous intraepithelial lesion.
2 d in a nested case-control study of cervical squamous intraepithelial lesions.
3 are stained in both low-grade and high-grade squamous intraepithelial lesions.
4 , and low-grade (LSIL) and high-grade (HSIL) squamous intraepithelial lesions.
5 amous intraepithelial lesions, or high-grade squamous intraepithelial lesions.
6 7% (95% CI, 2.5%-8.5%; I(2) = 0%) high-grade squamous intraepithelial lesions.
7  increased risk of progression to high-grade squamous intraepithelial lesions.
8 ons, and 40 participants (6%) had high-grade squamous intraepithelial lesions.
9 95% CI, 0.61-1.20) for those with high-grade squamous intraepithelial lesions.
10 s well as in a high proportion of high-grade squamous intraepithelial lesions.
11 most strongly associated with detection of a squamous intraepithelial lesions 4-8 months earlier (odd
12 e, 52 (0.5 percent of all smears); low-grade squamous intraepithelial lesion, 44 (0.5 percent); high-
13 thelial lesion, 44 (0.5 percent); high-grade squamous intraepithelial lesion, 6 (0.1 percent); and sq
14 cells of undetermined significance/low-grade squamous intraepithelial lesion (88.4%) or HPV16 was neg
15 re conducted with histologic anal high-grade squamous intraepithelial lesion (A-HSIL) as the dependen
16                              Anal high-grade squamous intraepithelial lesion (aHSIL) is the immediate
17 HPV, HPV16, and histological anal high-grade squamous intraepithelial lesions (aHSIL) were identified
18  to develop in patients with anal high-grade squamous intraepithelial lesions (aHSILs) on initial or
19                      Eleven of 33 high-grade squamous intraepithelial lesions and 1 of 12 low-grade s
20 s a risk predictor for virally-mediated anal squamous intraepithelial lesions and cancer (anal diseas
21 ssociated with the development of high-grade squamous intraepithelial lesions and invasive cervical c
22 s may explain the increased risk of cervical squamous intraepithelial lesions and invasive cervical c
23 n-regulated in SCCs compared with high-grade squamous intraepithelial lesions and normal squamous epi
24 s of undetermined significance and low-grade squamous intraepithelial lesion) and CIN1+ was also sign
25 gnificance, and 17.0% had high- or low-grade squamous intraepithelial lesions) and were significantly
26  cells, 149 participants (24%) had low-grade squamous intraepithelial lesions, and 40 participants (6
27 mavirus infection (HPV), low- and high-grade squamous intraepithelial lesions, and cervical cancer st
28 squamous intraepithelial lesions, high-grade squamous intraepithelial lesions, and SCC specimens.
29                    Genital HPV infection and squamous intraepithelial lesions are common among women
30 enrolled women with ICC, high- and low-grade squamous intraepithelial lesions, as well as, HPV-positi
31                                         Anal squamous intraepithelial lesions (ASIL) or anal intraepi
32 nce interval = 2.4-13.4) more likely to have squamous intraepithelial lesions associated with the det
33 determined significance [ASCUS] or low-grade squamous intraepithelial lesions) because of an ASCUS Pa
34 on and treatment of biopsy-proven high-grade squamous intraepithelial lesions (bHSIL) is difficult to
35                                 Precancerous squamous intraepithelial lesions can be detected by scre
36                       Cytological high-grade squamous intraepithelial lesions (cHSIL) incidence and c
37 roportion increased through ASCUS, low-grade squamous intraepithelial lesions, CIN1, and CIN2 (18%-25
38                   Among women with low-grade squamous intraepithelial lesion cytology, HC2 was more l
39  of undetermined significance and high-grade squamous intraepithelial lesion cytology.
40  combinations with either CIN2 or high-grade squamous intraepithelial lesion cytology; cluster 3 incl
41 cal squamous cells-cannot exclude high grade squamous intraepithelial lesion) for women who were posi
42 arated normal cervical tissues and low-grade squamous intraepithelial lesions from cervical cancers a
43 ntraepithelial lesions and 1 of 12 low-grade squamous intraepithelial lesions had abnormal Fhit expre
44  and treatment of anal histologic high-grade squamous intraepithelial lesions (hHSIL) prevents anal c
45 analysis of primary normal cervix, low grade squamous intraepithelial lesions, high-grade squamous in
46 nce (ASC-US) or as cannot exclude high-grade squamous intraepithelial lesion (HSIL) (ASC-H).
47 ficity for a combined endpoint of high-grade squamous intraepithelial lesion (HSIL) and anal intraepi
48  DNA methylation analysis of anal high-grade squamous intraepithelial lesion (HSIL) biopsies was show
49 avirus (HPV)-associated precancer high-grade squamous intraepithelial lesion (HSIL) in human immunode
50 the strategy for the detection of high-grade squamous intraepithelial lesion (HSIL) or worse.
51 ) spontaneous progression through high-grade squamous intraepithelial lesion (HSIL) to carcinoma, and
52        The anal cancer precursor, high-grade squamous intraepithelial lesion (HSIL), frequently regre
53 omen have a higher burden of anal high-grade squamous intraepithelial lesions (HSIL) and anal cancer
54 ca, are at high risk for cervical high-grade squamous intraepithelial lesions (HSIL) and cervical can
55 ca, are at high risk for cervical high-grade squamous intraepithelial lesions (HSIL) and cervical can
56 redict anal HPV16 infection, anal high-grade squamous intraepithelial lesions (HSIL) and, hence, anal
57 elial lesions (LSIL, n = 14), and high-grade squamous intraepithelial lesions (HSIL) grade 2 (CIN2, n
58 nd serological predictors of anal high-grade squamous intraepithelial lesions (HSIL) in human immunod
59 al human papillomavirus (HPV) and high-grade squamous intraepithelial lesions (HSIL) in men can infor
60    If left untreated, a subset of high-grade squamous intraepithelial lesions (HSIL) of the cervix wi
61                                   High-grade squamous intraepithelial lesions (HSIL) or cervical intr
62 pithelial lesions (LSIL), 21 with high-grade squamous intraepithelial lesions (HSIL), and 28 with inv
63 traepithelial neoplasia (CIN2-3), high-grade squamous intraepithelial lesions (HSIL), and invasive ce
64 gy (LAST) in low-grade (LSIL) and high-grade squamous intraepithelial lesions (HSIL), and the AIN cla
65 al history of its precursor, anal high-grade squamous intraepithelial lesions (HSIL).
66 ility is high and high-threshold (high-grade squamous intraepithelial lesion [HSIL] on cytology) if a
67 lude high-grade lesion [ASC-H] or high-grade squamous intraepithelial lesion [HSIL] with positive HPV
68 or managing premalignant lesions (high-grade squamous intraepithelial lesions [HSIL]) associated with
69  most instances, women with ASC-H, low-grade squamous intraepithelial lesion, HSIL, and atypical glan
70                              Anal high-grade squamous intraepithelial lesions (HSILs) ablation may re
71 llomavirus can cause preinvasive, high-grade squamous intraepithelial lesions (HSILs) as precursors t
72 2173 with low-grade and 1282 with high-grade squamous intraepithelial lesions (HSILs) diagnosed cytol
73 etection and determinants of anal high-grade squamous intraepithelial lesions (HSILs) in men who have
74 e, but more than one third of the high-grade squamous intraepithelial lesions (HSILs) in screening po
75                              Anal high-grade squamous intraepithelial lesions (HSILs) precede anal ca
76 s) and the anal cancer precursor, high-grade squamous intraepithelial lesions (HSILs), among young MS
77 illomavirus (HPV)-associated anal high-grade squamous intraepithelial lesions (HSILs).
78 ancer, anal cancer is preceded by high-grade squamous intraepithelial lesions (HSILs).
79 istically associated with risk of high-grade squamous intraepithelial lesions (HSILs).
80 ents with focal intra-anal tissue high-grade squamous intraepithelial lesions (HSILs).
81  cervical cancers and most of the high-grade squamous intraepithelial lesions (HSILs).
82 nts had invasive cervical cancer, high-grade squamous intraepithelial lesions (HSILs; n=166), or low-
83 IN-2 if concurrent with cytologic high grade squamous intraepithelial lesions [HSILs]).
84 is of cervical cancer precursors (high-grade squamous intraepithelial lesions [HSILs]).
85  >/=2 years and/or progression to high-grade squamous intraepithelial lesions (ie, cervical intraepit
86 ex with men, HPV DNA was detected in 19% and squamous intraepithelial lesions in 14%.
87 tions may explain the increased incidence of squamous intraepithelial lesions in HIV-seropositive wom
88  DLS in the detection of low- and high-grade squamous intraepithelial lesions in Papanicolaou test wh
89 tiate low-grade (LSIL) and high grade (HSIL) squamous intraepithelial lesions, in the cervix and anus
90  squamous cells, cannot exclude a high-grade squamous intraepithelial lesion, low-grade squamous intr
91 etermined significance (ASCUS) and low-grade squamous intraepithelial lesion (LSIL) triage study (ALT
92  positive HPV test, and persistent low-grade squamous intraepithelial lesion (LSIL) were significantl
93  also in HIV-infected women with a low-grade squamous intraepithelial lesion (LSIL; benchmark indicat
94 e 16 (HPV-16) can lead to low- or high-grade squamous intraepithelial lesions (LSIL or HSIL).
95 etermined significance (ASC-US) or low-grade squamous intraepithelial lesions (LSIL) who were triaged
96 etermined significance (ASC-US) or low-grade squamous intraepithelial lesions (LSIL) who were triaged
97 e compared 66 women diagnosed with low-grade squamous intraepithelial lesions (LSIL), 21 with high-gr
98 pecimens, including normal cervix, low-grade squamous intraepithelial lesions (LSIL), high-grade SILs
99 pical squamous cells (ASC, n = 5), low-grade squamous intraepithelial lesions (LSIL, n = 14), and hig
100 etermined significance [ASC-US] or low-grade squamous intraepithelial lesion [LSIL]) and a positive H
101 e is known about the prevalence of low-grade squamous intraepithelial lesions (LSILs) and the anal ca
102                                    Low-grade squamous intraepithelial lesions (LSILs) have been descr
103 undetermined significance (ASCUS), low-grade squamous intraepithelial lesions (LSILs), and high-grade
104 thelial lesions (HSILs; n=166), or low-grade squamous intraepithelial lesions (LSILs); were positive
105 ultivariable analysis, a history of cervical squamous intraepithelial lesion (odds ratio [OR], 4.2; 9
106 ng cervical precancer, defined as high-grade squamous intraepithelial lesions of the cervix.
107                   In SA, cytology high-grade squamous intraepithelial lesion or greater (HSIL+) had b
108 ection of HPV16, HPV18, or both or low-grade squamous intraepithelial lesion or worse cytology had be
109 ction of HPV16, HPV18, or both or high-grade squamous intraepithelial lesion or worse cytology had hi
110         Biopsy-confirmed high-grade cervical squamous intraepithelial lesions or invasive cancer.
111 e squamous intraepithelial lesion, low-grade squamous intraepithelial lesions, or high-grade squamous
112 and/or recurrent high-grade CIN2+/high-grade squamous intraepithelial lesions post-treatment.
113                                   High-grade squamous intraepithelial lesion prevalence was similar d
114  (CTL) responses have a protective effect in squamous intraepithelial lesion (SIL) development.
115                 Local cervical treatment for squamous intraepithelial lesion (SIL) or cervical intrae
116 ollowing outcomes: high-risk HPV prevalence; squamous intraepithelial lesion (SIL) or cervical intrae
117 omen with cytologic evidence of a high-grade squamous intraepithelial lesion (SIL) were referred for
118 ction with MY09/MY11/HMB01 HPV primers), and squamous intraepithelial lesions (SIL) (by cytological e
119 V) infections, abnormal cervical smears, and squamous intraepithelial lesions (SIL) among women with
120  the benign (88%) and precancerous (92%) HPV squamous intraepithelial lesions (SIL) and colocalized t
121  been reported to be 1.2-83.3% for low-grade squamous intraepithelial lesions (SIL) and to be 13.3-83
122 ons between human papillomavirus (HPV), anal squamous intraepithelial lesions (SIL), and human immuno
123 n the natural history of the precursor, anal squamous intraepithelial lesions (SIL), are limited.
124                   Screening methods for anal squamous intraepithelial lesions (SILs) are suboptimal.
125  vitamin A (retinol) deficiency and cervical squamous intraepithelial lesions (SILs) in human immunod
126 ypes most commonly associated with low-grade squamous intraepithelial lesions (SILs) were 56 and 53.
127  test results, defined as at least low-grade squamous intraepithelial lesions (SILs), in 774 human im
128 rus (HIV) are at increased risk for cervical squamous intraepithelial lesions (SILs), the precursors
129 ory of the precursor to this carcinoma, anal squamous intraepithelial lesions (SILs).
130  was normal and 97 specimens from women with squamous intraepithelial lesions (SILs).
131 rapy (HAART) on HPV persistence and cervical squamous intraepithelial lesions (SILs).
132 infection (by polymerase chain reaction) and squamous intraepithelial lesions (SILs).
133 IV infection have a higher risk for cervical squamous intraepithelial lesions than do women without H
134 sed as the lesions progressed from low-grade squamous intraepithelial lesions to HSILs and finally to
135 ogression of human papillomavirus-associated squamous intraepithelial lesions to invasive cervical ca
136 cells of undetermined significance-low-grade squamous intraepithelial lesion triage study (ALTS).
137 Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS, 1997
138 Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study provided bl
139 s of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study who were tr
140 cells of undetermined significance-low-grade squamous intraepithelial lesion triage study with the us
141 s of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study, in which w
142 etermined Significance (ASCUS) and Low-Grade Squamous Intraepithelial Lesion Triage Study.
143 Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS), we
144 Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion) Triage Study and who re
145 logy, the pooled prevalence estimate of anal squamous intraepithelial lesions was 22.4% (95% CI, 17.3
146         An elevated risk for high-grade anal squamous intraepithelial lesions was associated with inf
147                 The prevalence of high-grade squamous intraepithelial lesions was strongly related to
148 grade disease (ie, CIN 2 or 3, or high-grade squamous intraepithelial lesion) was 6.09 (3.87-9.60) co
149 nt condom use by their partners, no cervical squamous intraepithelial lesions were detected in 32 pat
150                                   High-grade squamous intraepithelial lesions were identified in 47 (
151                                              Squamous intraepithelial lesions were present in 15% (17
152 wever, HIV-infected men with high-grade anal squamous intraepithelial lesions were significantly more
153  regression and progression rates of HPV and squamous intraepithelial lesions, were obtained from the
154 observed in HPV-positive cervical high-grade squamous intraepithelial lesions when compared with norm
155 s of undetermined significance and low-grade squamous intraepithelial lesions who are at higher and l
156  If left untreated, some cervical high-grade squamous intraepithelial lesions will progress to invasi

 
Page Top